logical cardioversion plays a significant role in the management of patients with recent-onset atrial fibrillation (AF). We are excited to expand our relationship with Cardiome and include BRINAVESS in our product offerings, said Paul Giannacopoulos, VIANEX's Chairman and CEO. BRINAVESS is a great fit in our well established hospital products line, and we are delighted that Cardiome has given